This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Valo Health, Inc., Forma Therapeutics, Inc., H. Lee Moffitt Cancer Center and Research Institute, Inc.. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 33 
2 out of 125 
1 out of 312 
Years Active: 2019-2025
Title: Chiara Conti: Innovator in HDAC11 Inhibitor Research
Introduction
Chiara Conti is a prominent inventor based in Belmont, MA (US), known for her significant contributions to the field of medical research. She holds three patents, focusing on innovative methods that utilize HDAC11 inhibitors for treating various diseases.
Latest Patents
Her latest patents include methods using HDAC11 inhibitors. The present invention provides methods and uses of inhibitors of histone deacetylase 11 (HDAC11) in the treatment of diseases and/or disorders, such as, for example, cell proliferative diseases. This groundbreaking work aims to advance therapeutic options for patients suffering from these conditions.
Career Highlights
Chiara has worked with notable organizations, including Forma Therapeutics, Inc. and H. Lee Moffitt Cancer Center and Research Institute, Inc. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to impactful research.
Collaborations
Some of her coworkers include Jennifer Lee and Nicholas Barczak, who have played a role in her research endeavors.
Conclusion
Chiara Conti's innovative work in HDAC11 inhibitors showcases her dedication to advancing medical science and improving treatment options for various diseases. Her contributions are paving the way for future breakthroughs in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile